Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children’s ADHD medicine that it knew might be ineffective to the state’s Medicaid insurance program for low-income people, in a lawsuit unsealed yesterday.
https://www.pharmalive.com/wp-content/uploads/2022/05/Pfizer-keeps-COVID-sales-forecast-unchanged-as-pandemic-curbs-ease-Reuters-5-3-22.webp503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-11-20 19:40:162023-11-21 10:08:12Texas AG sues Pfizer over quality-control lapses in kids’ ADHD drug
